ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RP RepliCel Life Sciences Inc

0.055
0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 415k1.83M846k3.23M419k420k592k798k
Total Current Assets 394k1.81M835k3M223k185k393k636k
Cash and Equivalents 176k61k497k2.42M24k34k221k413k
Total Non-Current Assets -602k1.21M-320k-455k-2.93M-5.06M-6.84M-5.92M
Total Liabilities 1.02M622k1.17M3.68M3.35M5.48M7.44M6.71M
Total Current Liabilities 1.02M622k1.17M1.53M1.45M2.24M1.67M2.07M
Total Non-Current Liabilities 0002.15M1.9M3.27M5.8M4.68M
Total Equity -602k1.21M-320k-455k-2.93M-5.06M-6.84M-5.92M
Common Equity 16.5M21.91M26.18M28.75M28.96M28.47M30.29M31.66M
Retained Earnings -20.5M-24.78M-30.79M-33.56M-36.51M-38.16M-42.23M-42.97M